{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:25:28Z","timestamp":1793791528823,"version":"4.6.1"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.biopha.2024.116377","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T01:13:01Z","timestamp":1709601181000},"page":"116377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Glycogen synthase kinase-3: A potential immunotherapeutic target in tumor microenvironment"],"prefix":"10.1016","volume":"173","author":[{"given":"Jingyi","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1034\/j.1399-3011.1999.00083.x","article-title":"Expression analysis of glycogen synthase kinase-3 in human tissues[J]","volume":"54","author":"Lau","year":"1999","journal-title":"J. Pept. Res.: Off. J. Am. Pept. Soc."},{"issue":"5","key":"10.1016\/j.biopha.2024.116377_bib2","first-page":"661","article-title":"In Silico-motivated discovery of novel potent glycogen synthase-3 inhibitors: 1-(Alkyl\/arylamino)-3H-naphtho[1,2,3-de]quinoline-2,7-dione identified as a Scaffold for kinase inhibitor development[J]","volume":"16","author":"Emmerich","year":"2023","journal-title":"Pharm. (Basel, Switz. )"},{"issue":"8","key":"10.1016\/j.biopha.2024.116377_bib3","doi-asserted-by":"crossref","first-page":"7541","DOI":"10.3390\/ijms24087541","article-title":"GSK-3\u03b2 allosteric inhibition: a dead end or a new pharmacological Frontier?[J]","volume":"24","author":"Balboni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2024.116377_bib4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.122.321431","article-title":"Fibroblast GSK-3\u03b1 promotes fibrosis via RAF-MEK-ERK pathway in the injured heart[J]","volume":"131","author":"Umbarkar","year":"2022","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.biopha.2024.116377_bib5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cmet.2019.01.005","article-title":"Glycogen synthase kinase-3\u03b1 promotes fatty acid uptake and lipotoxic cardiomyopathy[J]","volume":"29","author":"Nakamura","year":"2019","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.biopha.2024.116377_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/jnc.12230","article-title":"GSK-3\u03b1\/\u03b2-mediated phosphorylation of CRMP-2 regulates activity-dependent dendritic growth[J]","volume":"125","author":"Tan","year":"2013","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.biopha.2024.116377_bib7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/toxsci\/kft158","article-title":"Serine 9 and tyrosine 216 phosphorylation of GSK-3\u03b2 differentially regulates autophagy in acquired cadmium resistance[J]","volume":"135","author":"Park","year":"2013","journal-title":"Toxicol. Sci.: Off. J. Soc. Toxicol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116377_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118659","article-title":"GSK-3\u03b2 in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer[J]","volume":"1867","author":"Lin","year":"2020","journal-title":"Biochim. Et. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.biopha.2024.116377_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106663","article-title":"Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3\u03b2 inhibitors for Alzheimer\u2019s disease[J]","volume":"138","author":"Yan","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"13","key":"10.1016\/j.biopha.2024.116377_bib10","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/1389450122666210120144428","article-title":"GSK-3 Inhibitors as New Leads to Treat Type-II Diabetes[J]","volume":"22","author":"Srivani","year":"2021","journal-title":"Curr. Drug Targets"},{"issue":"6","key":"10.1016\/j.biopha.2024.116377_bib11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/s12276-023-01009-w","article-title":"Peli3 ablation ameliorates acetaminophen-induced liver injury through inhibition of GSK3\u03b2 phosphorylation and mitochondrial translocation[J]","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med"},{"issue":"7","key":"10.1016\/j.biopha.2024.116377_bib12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.122.321431","article-title":"Fibroblast GSK-3\u03b1 promotes fibrosis via RAF-MEK-ERK pathway in the injured heart[J]","volume":"131","author":"Umbarkar","year":"2022","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2024.116377_bib13","unstructured":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases - PubMed[EB\/OL]. \/2024-02-19. \u3008https:\/\/pubmed.ncbi.nlm.nih.gov\/25435019\/\u3009."},{"issue":"24","key":"10.1016\/j.biopha.2024.116377_bib14","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.3390\/molecules26247629","article-title":"Carpachromene ameliorates insulin resistance in HepG2 cells via modulating IR\/IRS1\/PI3k\/Akt\/GSK3\/FoxO1 pathway[J]","volume":"26","author":"Alaaeldin","year":"2021","journal-title":"Mol. (Basel, Switz. )"},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13058-019-1125-0","article-title":"GSK3\u03b2 regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer[J]","volume":"21","author":"Vijay","year":"2019","journal-title":"Breast Cancer Res.: BCR"},{"key":"10.1016\/j.biopha.2024.116377_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/srep38553","article-title":"GSK-3\u03b2 controls NF-kappaB activity via IKK\u03b3\/NEMO[J]","volume":"6","author":"Medunjanin","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2024.116377_bib17","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00109-023-02373-w","article-title":"GSK-3\u03b1 aggravates inflammation, metabolic derangement, and cardiac injury post-ischemia\/reperfusion[J]","volume":"101","author":"Ahmad","year":"2023","journal-title":"J. Mol. Med. (Berl., Ger. )"},{"issue":"6","key":"10.1016\/j.biopha.2024.116377_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061427","article-title":"The role of GSK-3 in cancer immunotherapy: GSK-3 inhibitors as a new Frontier in cancer treatment[J]","volume":"9","author":"Augello","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2024.116377_bib19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth[J]","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.biopha.2024.116377_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2018.02.012","article-title":"Mitochondria-endoplasmic reticulum contact sites function as immunometabolic hubs that orchestrate the rapid recall response of memory CD8+ T Cells[J]","volume":"48","author":"Bantug","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/15384047.2022.2088984","article-title":"Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3\u03b2) inhibitor, in refractory adult T-Cell leukemia\/lymphoma[J]","volume":"23","author":"Hsu","year":"2022","journal-title":"Cancer Biol. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2024.116377_bib22","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.3390\/cancers13081802","article-title":"GSK-3\u03b1 inhibition in drug-resistant CML cells promotes susceptibility to NK Cell-mediated lysis in an NKG2D- and NKp30-dependent manner[J]","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.biopha.2024.116377_bib23","article-title":"Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma[J]. Cell Reports","volume":"4","author":"Pang","year":"2023","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.biopha.2024.116377_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005655","article-title":"Macrophage GSK3\u03b2-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy[J]","volume":"10","author":"Sun","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2024.116377_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/ijo.2023.5599","article-title":"Research progress on the role of tumor\u2011associated macrophages in tumor development and their use as molecular targets (Review)[J]","volume":"64","author":"Lu","year":"2024","journal-title":"Int. J. Oncol."},{"issue":"44","key":"10.1016\/j.biopha.2024.116377_bib26","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1038\/onc.2009.247","article-title":"Macrophage-derived IL-1\u03b2 stimulates Wnt signaling and growth of colon cancer cells; a crosstalk interrupted by vitamin D3[J]","volume":"28","author":"Kaler","year":"2009","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biopha.2024.116377_bib27","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.21037\/tcr.2020.02.52","article-title":"IL-1\u03b2 secreted by macrophage M2 promotes metastasis of osteosarcoma via NF-\u03baB\/miR-181\u03b1-5p\/RASSF1A\/Wnt pathway[J]","volume":"9","author":"Han","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"33","key":"10.1016\/j.biopha.2024.116377_bib28","doi-asserted-by":"crossref","first-page":"34758","DOI":"10.18632\/oncotarget.5325","article-title":"CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer[J]","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.biopha.2024.116377_bib29","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1053\/j.gastro.2018.08.028","article-title":"An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice[J]","volume":"155","author":"Edderkaoui","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.biopha.2024.116377_bib30","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/liv.15094","article-title":"Aurora kinase A regulates liver regeneration through macrophages polarization and Wnt\/\u03b2-catenin signalling[J]","volume":"42","author":"Yin","year":"2022","journal-title":"Liver Int.: Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.biopha.2024.116377_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120032","article-title":"Aloe polymeric acemannan inhibits the cytokine storm in mouse pneumonia models by modulating macrophage metabolism[J]","volume":"297","author":"Li","year":"2022","journal-title":"Carbohydr. Polym."},{"issue":"11","key":"10.1016\/j.biopha.2024.116377_bib32","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/cns.13715","article-title":"Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti-inflammatory microglia\/macrophages phenotype polarization through GSK-3\u03b2\/Nrf2 pathway[J]","volume":"27","author":"Cai","year":"2021","journal-title":"CNS Neurosci. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2024.116377_bib33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/TP.0000000000003446","article-title":"Inhibition of Glycogen Synthase Kinase 3\u03b2 Alleviates Chronic Renal Allograft Dysfunction in Rats[J]","volume":"105","author":"Deng","year":"2021","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.biopha.2024.116377_bib34","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/ATVBAHA.118.311363","article-title":"Inhibiting Glycogen Synthase Kinase 3 Reverses Obesity-Induced White Adipose Tissue Inflammation by Regulating Apoptosis Inhibitor of Macrophage\/CD5L-Mediated Macrophage Migration[J]","volume":"38","author":"Wang","year":"2018","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"10.1016\/j.biopha.2024.116377_bib35","article-title":"Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity[J]","volume":"7","author":"Li","year":"2016","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2024.116377_bib36","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cellsig.2015.05.012","article-title":"NK cell function triggered by multiple activating receptors is negatively regulated by glycogen synthase kinase-3\u03b2[J]","volume":"27","author":"Kwon","year":"2015","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.biopha.2024.116377_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bcp.2010.09.026","article-title":"The anti-tumoral drug enzastaurin inhibits natural killer cell cytotoxicity via activation of glycogen synthase kinase-3\u03b2[J]","volume":"81","author":"Ogbomo","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116377_bib38","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.3390\/cancers13081802","article-title":"GSK-3\u03b1 Inhibition in Drug-Resistant CML Cells Promotes Susceptibility to NK Cell-Mediated Lysis in an NKG2D- and NKp30-Dependent Manner[J]","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.biopha.2024.116377_bib39","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.4049\/jimmunol.1201426","article-title":"Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell\u2013Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3[J]","volume":"190","author":"Fionda","year":"2013","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116377_bib40","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/jcmm.13025","article-title":"The TGF-\u03b2-induced up-regulation of NKG2DLs requires AKT\/GSK-3\u03b2-mediated stabilization of SP1[J]","volume":"21","author":"Chen","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2024.116377_bib41","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/eji.201948284","article-title":"Glycogen synthetase kinase 3 inhibition drives MIC-A\/B to promote cytokine production by human natural killer cells in Dengue virus type 2 infection[J]","volume":"50","author":"Petitdemange","year":"2020","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116377_bib42","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1189\/jlb.2A0816-342R","article-title":"IL-18-dependent NKG2D ligand upregulation on accessory cells is mediated by the PI3K\/GSK-3 pathway[J]","volume":"101","author":"Brandstadter","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"20","key":"10.1016\/j.biopha.2024.116377_bib43","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1158\/0008-5472.CAN-17-0799","article-title":"GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity[J]","volume":"77","author":"Cichocki","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2024.116377_bib44","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3389\/fimmu.2020.01638","article-title":"GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response[J]","volume":"11","author":"Rudd","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116377_bib45","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.4049\/jimmunol.174.8.4551","article-title":"Role for Glycogen Synthase Kinase-3 in NK Cell Cytotoxicity and X-Linked Lymphoproliferative Disease[J]","volume":"174","author":"Aoukaty","year":"2005","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.20892\/j.issn.2095-3941.2018.0253","article-title":"The PI3K\/Akt\/GSK-3\u03b2\/ROS\/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility[J]","volume":"16","author":"Fengjiao","year":"2019","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11154","article-title":"Repression of GSK3 restores NK cell cytotoxicity in AML patients[J]","volume":"7","author":"Parameswaran","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116377_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejphar.2018.08.033","article-title":"Isoliquiritigenin inhibits mouse S180 tumors with a new mechanism that regulates autophagy by GSK-3\u03b2\/TNF-\u03b1 pathway[J]","volume":"838","author":"Yushan","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116377_bib49","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201658RR","article-title":"GSK-3\u03b2\/\u03b2-catenin pathway plays crucial roles in the regulation of NK cell cytotoxicity against myeloma cells[J]","volume":"37","author":"Ren","year":"2023","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.biopha.2024.116377_bib50","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.4049\/jimmunol.1303354","article-title":"Survival and Inflammation Promotion Effect of PTPRO in Fulminant Hepatitis Is Associated with NF-\u03baB Activation[J]","volume":"193","author":"Jiang","year":"2014","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116377_bib51","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/intimm\/dxp035","article-title":"Lysophosphatidic acid inhibits the cytotoxic activity of NK cells: involvement of Gs protein-mediated signaling[J]","volume":"21","author":"Lagadari","year":"2009","journal-title":"Int. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116377_bib52","article-title":"Evaluating a New Class of AKT\/mTOR Activators for HIV Latency-Reversing Activity Ex Vivo and In Vivo[J]","volume":"95","author":"Gramatica","year":"2021","journal-title":"F. Kirchhoff. J. Virol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116377_bib53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ni.3664","article-title":"Gsk3 is a metabolic checkpoint regulator in B cells[J]","volume":"18","author":"Jellusova","year":"2017","journal-title":"Nat. Immunol."},{"issue":"7657","key":"10.1016\/j.biopha.2024.116377_bib54","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature22353","article-title":"The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3\u03b2 inhibition[J]","volume":"546","author":"Varano","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hon.2694","article-title":"New responsibilities for aged kinases in B-lymphomas[J]","volume":"38","author":"Piazza","year":"2020","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.biopha.2024.116377_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.603288","article-title":"Inhibition of Glycogen Synthase Kinase 3\u03b2 Increases the Proportion and Suppressive Function of CD19+CD24hiCD27+ Breg Cells[J]","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."},{"issue":"7217","key":"10.1016\/j.biopha.2024.116377_bib57","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nature07284","article-title":"Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy[J]","volume":"455","author":"Wang","year":"2008","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2024.116377_bib58","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41385-021-00481-9","article-title":"Glutaminolysis is required in maintaining immune regulatory functions in B cells[J]","volume":"15","author":"Liu","year":"2022","journal-title":"Mucosal Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116377_bib59","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/eji.202149387","article-title":"Glutamine promotes the generation of B10+ cells via the mTOR\/GSK3 pathway[J]","volume":"52","author":"Mielle","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2024.116377_bib60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canlet.2018.06.035","article-title":"Glycogen synthase kinase 3 inhibition lowers PD-1 expression, promotes long-term survival and memory generation in antigen-specific CAR-T cells[J]","volume":"433","author":"Sengupta","year":"2018","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.biopha.2024.116377_bib61","first-page":"319","article-title":"Effects of Glycogen Synthase Kinase-3\u03b2 Inhibitor TWS119 on Proliferation and Cytokine Production of TILs From Human Lung Cancer[J]","volume":"41","author":"Tang","year":"2018","journal-title":"J. Immunother. (Hagerstown, Md.: 1997)"},{"issue":"3","key":"10.1016\/j.biopha.2024.116377_bib62","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2018.02.012","article-title":"Mitochondria-Endoplasmic Reticulum Contact Sites Function as Immunometabolic Hubs that Orchestrate the Rapid Recall Response of Memory CD8+ TCells[J]","volume":"48","author":"Bantug","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib63","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13045-022-01352-x","article-title":"Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8+ T cell cytolytic killing of melanoma cells[J]","volume":"15","author":"Shaw","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116377_bib64","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1158\/0008-5472.CAN-17-0491","article-title":"Small-Molecule Inhibition of PD-1 Transcription Is an Effective Alternative to Antibody Blockade in Cancer Therapy[J]","volume":"78","author":"Taylor","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2024.116377_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120635","article-title":"Immune checkpoint inhibition in syngeneic mouse cancer models by a silicasome nanocarrier delivering a GSK3 inhibitor[J]","volume":"269","author":"Allen","year":"2021","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biopha.2024.116377_bib66","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","article-title":"Cancer-cell-derived GABA promotes \u03b2-catenin-mediated tumour growth and immunosuppression[J]","volume":"24","author":"Huang","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116377_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004026","article-title":"eEF2K promotes PD-L1 stabilization through inactivating GSK3\u03b2 in melanoma[J]","volume":"10","author":"Chen","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib68","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1038\/s41467-021-23864-9","article-title":"WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression[J]","volume":"12","author":"Wu","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2024.116377_bib69","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3390\/cells9061424","article-title":"Glycogen Synthase Kinase-3\u03b2 Facilitates Cytokine Production in 12-O-Tetradecanoylphorbol-13-Acetate\/Ionomycin-Activated Human CD4+ T Lymphocytes[J]","volume":"9","author":"Tsai","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2024.116377_bib70","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41590-021-01090-1","article-title":"The kinase complex mTORC2 promotes the longevity of virus-specific memory CD4+ T cells by preventing ferroptosis[J]","volume":"23","author":"Wang","year":"2022","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib71","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41467-018-02897-7","article-title":"Gimap5-dependent inactivation of GSK3\u03b2 is required for CD4+ T cell homeostasis and prevention of immune pathology[J]","volume":"9","author":"Patterson","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116377_bib72","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.2147\/DDDT.S269725","article-title":"The HSP90 Inhibitor, 17-AAG, influences the activation and proliferation of t lymphocytes via AKT\/GSK3\u03b2 signaling in MRL\/lpr mice[J]","volume":"Volume 14","author":"Hong","year":"2020","journal-title":"Drug Des., Dev. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2024.116377_bib73","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41419-022-05002-5","article-title":"Identification of an Epi-metabolic dependency on EHMT2\/G9a in T-cell acute lymphoblastic leukemia[J]","volume":"13","author":"Montanaro","year":"2022","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.biopha.2024.116377_bib74","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2213793120","article-title":"Liver X receptor controls follicular helper T cell differentiation via repression of TCF-1[J]","volume":"120","author":"Kim","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib75","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/22221751.2022.2026198","article-title":"Pharmacological suppression of glycogen synthase kinase-3 reactivates HIV-1 from latency via activating Wnt\/\u03b2-catenin\/TCF1 axis in CD4 + T cells[J]","volume":"11","author":"Wen","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"4","key":"10.1016\/j.biopha.2024.116377_bib76","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/imm.13199","article-title":"Glycogen synthase kinase-3 promotes T helper type 17 differentiation by promoting interleukin-9 production[J]","volume":"160","author":"Han","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2024.116377_bib77","unstructured":"As A.-Z. Differential time course of glycogen synthase kinase-3 inhibition in experimental autoimmune encephalomyelitis[J]. Malays J Pathol, 2021."},{"issue":"3","key":"10.1016\/j.biopha.2024.116377_bib78","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1021\/acschembio.9b00075","article-title":"A phenotypic screening approach using human treg cells identified regulators of Forkhead Box p3 Expression[J]","volume":"14","author":"Ding","year":"2019","journal-title":"ACS Chem. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116377_bib79","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.4049\/jimmunol.2000136","article-title":"Cutting Edge: Inhibition of Glycogen Synthase Kinase 3 Activity Induces the Generation and Enhanced Suppressive Function of Human IL-10+ FOXP3+\u2013Induced Regulatory T Cells[J]","volume":"205","author":"Cheng","year":"2020","journal-title":"J. Immunol. Author Choice"},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib80","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12943-021-01420-9","article-title":"AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR\/p38 signaling pathway[J]","volume":"20","author":"Pokhrel","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2024.116377_bib81","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ebiom.2019.01.054","article-title":"SA-49, a novel aloperine derivative, induces MITF-dependent lysosomal degradation of PD-L1[J]","volume":"40","author":"Zhang","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib82","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yexcr.2017.11.003","article-title":"Wnt pathway activator TWS119 enhances the proliferation and cytolytic activity of human \u03b3\u03b4T cells against colon cancer[J]","volume":"362","author":"Chen","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib83","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13104-020-04971-0","article-title":"Glycogen synthase kinase 3 (GSK-3) controls T-cell motility and interactions with antigen presenting cells[J]","volume":"13","author":"Taylor","year":"2020","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.biopha.2024.116377_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.680071","article-title":"GSK3\u03b2 Interacts With CRMP2 and Notch1 and Controls T-Cell Motility[J]","volume":"12","author":"Fazil","year":"2021","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.biopha.2024.116377_bib85","doi-asserted-by":"crossref","first-page":"12394","DOI":"10.1074\/jbc.M114.628578","article-title":"Glycogen synthase kinase-3\u03b2 (GSK-3\u03b2) inhibition enhances dendritic cell-based cancer vaccine potency via suppression of interferon-\u03b3-induced indoleamine 2,3-dioxygenase expression[J]","volume":"290","author":"Noh","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2024.116377_bib86","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3109\/13693780903420625","article-title":"Role of Glycogen Synthase Kinase 3 (GSK-3) in innate immune response of human immature dendritic cells to Aspergillus fumigatus[J]","volume":"48","author":"Spinnler","year":"2010","journal-title":"Med. Mycol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116377_bib87","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4049\/jimmunol.1003511","article-title":"Glycogen Synthase Kinase-3 Is an Early Determinant in the Differentiation of Pathogenic Th17 Cells[J]","volume":"186","author":"Beurel","year":"2011","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116377_bib88","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2567.2007.02627.x","article-title":"Glycogen synthase kinase 3 activity during development of bone marrow-derived dendritic cells (DCs) essential for the DC function to induce T helper 2 polarization[J]","volume":"122","author":"Ono","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2024.116377_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.588500","article-title":"Granulocytic Myeloid-Derived Suppressor Cell Exosomal Prostaglandin E2 Ameliorates Collagen-Induced Arthritis by Enhancing IL-10+ B Cells[J]","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116377_bib90","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/1878-0261.13289","article-title":"Slit2\/Robo1 signaling inhibits small-cell lung cancer by targeting \u03b2-catenin signaling in tumor cells and macrophages[J]","volume":"17","author":"Ahirwar","year":"2023","journal-title":"Mol. Oncol."},{"issue":"48","key":"10.1016\/j.biopha.2024.116377_bib91","doi-asserted-by":"crossref","first-page":"7294","DOI":"10.1038\/s41388-019-0951-y","article-title":"MUC13 promotes the development of colitis-associated colorectal tumors via \u03b2-catenin activity[J]","volume":"38","author":"Sheng","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib92","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives[J]","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2024.116377_bib93","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ebiom.2018.09.006","article-title":"Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p[J]","volume":"36","author":"Li","year":"2018","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.biopha.2024.116377_bib94","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/carcin\/bgz205","article-title":"Epidermal ROCK2 induces AKT1\/GSK3\u03b2\/\u03b2-catenin, NF\u03baB and dermal tenascin C; but enhanced differentiation and p53\/p21 inhibit papilloma[J]","volume":"41","author":"Masre","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2024.116377_bib95","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.12659\/MSM.902870","article-title":"Cancer-Associated Fibroblasts Autophagy Enhances Progression of Triple-Negative Breast Cancer Cells[J]","volume":"23","author":"Wang","year":"2017","journal-title":"Med. Sci. Monit."},{"issue":"8","key":"10.1016\/j.biopha.2024.116377_bib96","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191805","article-title":"Acidic fibroblast growth factor underlies microenvironmental regulation of MYC in pancreatic cancer[J]","volume":"217","author":"Bhattacharyya","year":"2020","journal-title":"J. Exp. Med."},{"issue":"728","key":"10.1016\/j.biopha.2024.116377_bib97","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3840","article-title":"The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets[J]","volume":"16","author":"Sleeboom","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.biopha.2024.116377_bib98","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3390\/cells10082092","article-title":"GSK3 as a Regulator of Cytoskeleton Architecture: Consequences for Health and Disease[J]","volume":"10","author":"Hajka","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.biopha.2024.116377_bib99","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1096\/fj.201701078R","article-title":"AMPK\/GSK3\u03b2\/\u03b2-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming[J]","volume":"32","author":"Zhang","year":"2018","journal-title":"FASEB J."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2024.116377_bib100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11010-018-3406-9","article-title":"CD147 (EMMPRIN) controls malignant properties of breast cancer cells by interdependent signaling of Wnt and JAK\/STAT pathways[J]","volume":"451","author":"Knutti","year":"2019","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.biopha.2024.116377_bib101","first-page":"960","article-title":"Targeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An Update[J]","volume":"9","author":"Duspara","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116377_bib102","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/intbio\/zyab009","article-title":"Cell surface integrin \u03b15\u00df1 clustering negatively regulates receptor tyrosine kinase signaling in colorectal cancer cells via glycogen synthase kinase 3[J]","volume":"13","author":"Starchenko","year":"2021","journal-title":"Integr. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib103","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1038\/s41598-020-59623-x","article-title":"Dietary AGEs involvement in colonic inflammation and cancer: insights from an in vitro enterocyte model[J]","volume":"10","author":"Geicu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116377_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.633054","article-title":"GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis[J]","volume":"8","author":"Cinetto","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2024.116377_bib105","article-title":"Dec1 Deficiency ameliorates pulmonary fibrosis through the PI3K\/AKT\/GSK-3\u03b2\/\u03b2-Catenin integrated signaling pathway[J]","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s10020-020-00173-3","article-title":"Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt\/GSK-3\u03b2\/\u03b2-catenin and TGF-\u03b21\/Smad2\/3 signaling pathways[J]","volume":"26","author":"Lv","year":"2020","journal-title":"Mol. Med. (Camb., Mass. )"},{"issue":"11","key":"10.1016\/j.biopha.2024.116377_bib107","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1007\/s11010-021-04219-w","article-title":"Role of PI3K\/Akt signaling pathway in cardiac fibrosis[J]","volume":"476","author":"Qin","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2024.116377_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152949","article-title":"Qishen granule attenuates cardiac fibrosis by regulating TGF-\u03b2 \/Smad3 and GSK-3\u03b2 pathway[J]","volume":"62","author":"Zeng","year":"2019","journal-title":"Phytomedicine: Int. J. Phytother. Phytopharm."},{"issue":"25","key":"10.1016\/j.biopha.2024.116377_bib109","doi-asserted-by":"crossref","first-page":"11737","DOI":"10.7150\/thno.47717","article-title":"Glycogen synthase kinase-3\u03b2: a promising candidate in the fight against fibrosis[J]","volume":"10","author":"Zheng","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2024.116377_bib110","article-title":"Reelin promotes cisplatin resistance by induction of epithelial-mesenchymal transition via p38\/GSK3\u03b2\/Snail signaling in non-small cell lung cancer[J]","volume":"26","author":"Li","year":"2020","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"issue":"9","key":"10.1016\/j.biopha.2024.116377_bib111","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/ar.24321","article-title":"RHAMM inhibits cell migration via the AKT\/GSK3\u03b2\/Snail axis in luminal A subtype breast cancer[J]","volume":"303","author":"Wang","year":"2020","journal-title":"Anat. Rec."},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib112","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1038\/s41467-021-22467-8","article-title":"ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation[J]","volume":"12","author":"Wu","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biopha.2024.116377_bib113","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1111\/cas.15110","article-title":"Chemokine C-C motif ligand 21 synergized with programmed death-ligand 1 blockade restrains tumor growth[J]","volume":"112","author":"Chen","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2024.116377_bib114","article-title":"Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity[J]","volume":"7","author":"Li","year":"2016","journal-title":"Nat. Commun."},{"issue":"30","key":"10.1016\/j.biopha.2024.116377_bib115","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1038\/s41388-018-0252-x","article-title":"Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin \u03b24\/SNAI1\/SIRT3 signaling pathway[J]","volume":"37","author":"Wang","year":"2018","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.biopha.2024.116377_bib116","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.celrep.2020.01.076","article-title":"Small molecule inhibition of GSK-3 specifically inhibits the transcription of inhibitory Co-receptor LAG-3 for enhanced anti-tumor immunity[J]","volume":"30","author":"Rudd","year":"2020","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.biopha.2024.116377_bib117","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/13543776.2020.1815706","article-title":"Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2016-2019)[J]","volume":"30","author":"Roca","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"10","key":"10.1016\/j.biopha.2024.116377_bib118","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.2174\/1570159X20666220411081728","article-title":"What is the role of lithium in epilepsy?[J]","volume":"20","author":"Bojja","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2024.116377_bib119","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fnmol.2019.00163","article-title":"Recruitment, retainment, and biomarkers of response; a pilot trial of lithium in humans with mild cognitive impairment[J]","volume":"12","author":"Duthie","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2024.116377_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.639402","article-title":"Rationale and design of assessing the effectiveness of short-term low-dose lithium therapy in averting cardiac surgery-associated acute kidney injury: a randomized, double blinded, placebo controlled pilot trial[J]","volume":"8","author":"Sharif","year":"2021","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.biopha.2024.116377_bib121","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nephro.2018.11.001","article-title":"[Renal toxicity of lithium][J]","volume":"15","author":"Servais","year":"2019","journal-title":"Nephrol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib122","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer\u2019s disease[J]","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimer\u2019S. Dis.: JAD"},{"key":"10.1016\/j.biopha.2024.116377_bib123","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pediatrneurol.2020.08.001","article-title":"A phase 2 study of AMO-02 (Tideglusib) in congenital and childhood-onset myotonic dystrophy type 1 (DM1)[J]","volume":"112","author":"Horrigan","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.biopha.2024.116377_bib124","unstructured":"Anagnostou E. A Randomized Placebo-controlled Trial of Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders (ASD)[R]. NCT02586935, clinicaltrials.gov, 2018."},{"key":"10.1016\/j.biopha.2024.116377_bib125","unstructured":"Hamilton Health Sciences Corporation. Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy[R]. NCT06174220, clinicaltrials.gov, 2024."},{"issue":"4","key":"10.1016\/j.biopha.2024.116377_bib126","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/biof.1640","article-title":"POTEE stimulates the proliferation of pancreatic cancer by activating the PI3K\/Akt\/GSK-3\u03b2\/\u03b2-catenin signaling[J","volume":"46","author":"Hao","year":"2020","journal-title":"BioFactors (Oxf., Engl. )"},{"key":"10.1016\/j.biopha.2024.116377_bib127","unstructured":"Eli Lilly and Company. A Phase 2 Study of LY2090314 in Participants With Acute Leukemia[R]. NCT01214603, clinicaltrials.gov, 2018."},{"key":"10.1016\/j.biopha.2024.116377_bib128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mam.2019.10.001","article-title":"The role of exosomes and MYC in therapy resistance of acute myeloid leukemia: challenges and opportunities[J]","volume":"70","author":"Mudgapalli","year":"2019","journal-title":"Mol. Asp. Med."},{"issue":"6","key":"10.1016\/j.biopha.2024.116377_bib129","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10637-015-0278-7","article-title":"A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin[J]","volume":"33","author":"Gray","year":"2015","journal-title":"Investig. N. Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","article-title":"Wnt\/\u03b2-catenin-driven EMT regulation in human cancers[J]","volume":"81","author":"Xue","year":"2024","journal-title":"Cell. Mol. life Sci.: CMLS"},{"issue":"11","key":"10.1016\/j.biopha.2024.116377_bib131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013879","article-title":"Inhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8[J]","volume":"5","author":"Aguilar-Morante","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2024.116377_bib132","unstructured":"Saeed A. A Phase 2 Study of 9-ING-41, a Glycogen Synthase Kinase 3-beta (GSK-3\u03b2) Inhibitor, Combined With Retifanlimab, a PD-1 Inhibitor, Plus Gemcitabine\/Nab-Paclitaxel as Frontline Therapy for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)[R]. NCT05239182, clinicaltrials.gov, 2023."},{"key":"10.1016\/j.biopha.2024.116377_bib133","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejphar.2018.08.033","article-title":"Isoliquiritigenin inhibits mouse S180 tumors with a new mechanism that regulates autophagy by GSK-3\u03b2\/TNF-\u03b1 pathway[J]","volume":"838","author":"Yushan","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2024.116377_bib134","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1021\/acs.jmedchem.0c02254","article-title":"Discovery of novel benzothiazepinones as irreversible covalent glycogen synthase kinase 3\u03b2 inhibitors for the treatment of acute promyelocytic leukemia[J]","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116377_bib135","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ejmech.2017.04.039","article-title":"The discovery of novel benzothiazinones as highly selective non-ATP competitive glycogen synthase kinase 3\u03b2 inhibitors for the treatment of ovarian cancer[J]","volume":"135","author":"Gao","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2024.116377_bib136","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201658RR","article-title":"GSK-3\u03b2\/\u03b2-catenin pathway plays crucial roles in the regulation of NK cell cytotoxicity against myeloma cells[J]","volume":"37","author":"Ren","year":"2023","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib137","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1124\/jpet.117.245738","article-title":"In vitro and in vivo antitumor and anti-inflammatory capabilities of the novel GSK3 and CDK9 inhibitor ABC1183[J]","volume":"365","author":"Schrecengost","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"431","key":"10.1016\/j.biopha.2024.116377_bib138","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam8460","article-title":"Exploiting an Asp-Glu \u201cswitch\u201d in glycogen synthase kinase 3 to design paralog selective inhibitors for use in acute myeloid leukemia[J]","volume":"10","author":"Wagner","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2024.116377_bib139","article-title":"Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy[J]","volume":"167","author":"Guil-Luna","year":"2023","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib140","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2230388","article-title":"PD-L1 dimerisation induced by biphenyl derivatives mediates anti-breast cancer activity via the non-immune PD-L1-AKT-mTOR\/Bcl2 pathway[J]","volume":"38","author":"Zhang","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2024.116377_bib141","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/15384047.2022.2088984","article-title":"Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3\u03b2) inhibitor, in refractory adult T-Cell leukemia\/lymphoma[J]","volume":"23","author":"Hsu","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.biopha.2024.116377_bib142","doi-asserted-by":"crossref","unstructured":"eEF2K promotes PD-L1 stabilization through inactivating GSK3\u03b2 in melanoma - PubMed[EB\/OL]. \/2023-10-21. \u3008https:\/\/pubmed.ncbi.nlm.nih.gov\/35347072\/\u3009.","DOI":"10.1136\/jitc-2021-004026"},{"issue":"3","key":"10.1016\/j.biopha.2024.116377_bib143","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/cancers15030705","article-title":"Deletion of Glycogen Synthase Kinase 3 Beta Reprograms NK Cell Metabolism[J]","volume":"15","author":"Pereira","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.116377_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175836","article-title":"Perillaldehyde improves diabetic cardiomyopathy by upregulating miR-133a-3p to regulate GSK-3\u03b2[J]","volume":"953","author":"Yu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116377_bib145","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/cns.14143","article-title":"MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3\u03b2, APPBP2, and mTOR in Alzheimer\u2019s disease[J]","volume":"29","author":"Li","year":"2023","journal-title":"CNS Neurosci. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2024.116377_bib146","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1615\/CritRevEukaryotGeneExpr.2023048344","article-title":"Exosome-mediated lncRNA LINC01140 attenuates breast cancer progression by regulating the Wnt\/\u03b2-catenin pathway[J].","volume":"33","author":"Guo","year":"2023","journal-title":"Crit. Rev. Eukaryot. Gene Expr."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224002610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224002610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:31:45Z","timestamp":1793788305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224002610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":146,"alternative-id":["S0753332224002610"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116377","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycogen synthase kinase-3: A potential immunotherapeutic target in tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116377"}}